Cargando…
A Rapid, Functional sgRNA Screening Method for Generating Murine RET and NTRK1 Fusion Oncogenes
CRISPR/Cas9 gene editing technology is an indispensable and powerful tool in the field of cancer biology. To conduct successful CRISPR-based experiments, it is crucial that sgRNAs generate their designed alterations. Here, we describe a simple and efficient sgRNA screening method for validating sgRN...
Autores principales: | Schubert, Laura, Le, Anh T., Hinz, Trista K., Navarro, Andre, Nelson-Taylor, Sarah K., Nemenoff, Raphael A., Heasley, Lynn E., Doebele, Robert C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10104125/ https://www.ncbi.nlm.nih.gov/pubmed/37066347 http://dx.doi.org/10.1101/2023.04.06.535912 |
Ejemplares similares
-
A functional sgRNA-CRISPR screening method for generating murine RET and NTRK1 rearranged oncogenes
por: Schubert, Laura, et al.
Publicado: (2023) -
Evaluation of KRAS(G12C) inhibitor responses in novel murine KRAS(G12C) lung cancer cell line models
por: Sisler, Daniel J., et al.
Publicado: (2023) -
Sequence determinants of improved CRISPR sgRNA design
por: Xu, Han, et al.
Publicado: (2015) -
Emerging oncogenic fusions other than ALK, ROS1, RET, and NTRK in NSCLC and the role of fusions as resistance mechanisms to targeted therapy
por: Suda, Kenichi, et al.
Publicado: (2020) -
Systematic population-based identification of NTRK and RET fusion-positive thyroid cancers
por: Eszlinger, Markus, et al.
Publicado: (2021)